Trial intelligence / Profile preview

Bioequivalence Study of Olmesartan Medoxomil 40 mg Film-coated Tablets in Healthy Thai Volunteers

TCTR20200622002Phase 1Not yet recruiting

Sponsor
International Bio Service
Start
Oct 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, randomised trial of olmesartan in hypertension (HTN) (2 arms), sponsored by International Bio Service. Planned start Oct 2020; status: not yet recruiting.

02

Drugs

olmesartan
03

Conditions

hypertension (HTN)

Beyond the preview

Go deeper on TCTR20200622002.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20200622002.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call